Skip to content
MMJ Gazette
  Wednesday 4 February 2026
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
January 31, 2026Colorado THC Vapes Flooded with Converted Hemp, Experts Sound Alarm January 29, 2026California Smashes Own Record: $609 Million in Illegal Cannabis Destroyed January 28, 2026Trump Allies Push to Kill Arizona Adult-Use Marijuana Sales January 18, 2026Florida’s Marijuana Legalization Battle Hits New Lows in 2026 January 16, 2026Montana Cannabis Sales Smash Records with $327 Million Haul January 15, 2026Cannabis M&A Surge Sparks Hope After Trump Order January 14, 2026Massachusetts Cannabis Ban Hit by Fraud Claims in 2026 Vote January 13, 2026Texas Medical Cannabis Set to Explode in 2026 January 10, 2026Cannabis Firms Face HR Compliance Crunch in 2026 January 9, 2026Oregon Cannabis Sales Drop in 2025 Despite Record Harvests
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Cannabis  Marijuana Goes National: 7 Industry Predictions for 2025
CannabisNews

Marijuana Goes National: 7 Industry Predictions for 2025

Lars BeckersLars Beckers—January 7, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

The U.S. marijuana industry stands on the brink of sweeping changes, with new opportunities and challenges looming large. A $32 billion sector could see long-awaited tax reforms, clearer regulatory frameworks, and even potential support from the highest political offices. Here’s a closer look at the key predictions shaping cannabis in 2025.

A Step Toward Schedule 3 Classification

The long-awaited reclassification of marijuana as a Schedule 3 drug is closer than ever. The DEA is expected to make a ruling after nearly a year of deliberation.

This decision could reshape the industry:

  • If approved, it would place marijuana in the same category as anabolic steroids and ketamine, signaling a softer stance toward the drug.
  • However, court challenges are inevitable, and the final outcome may remain mired in legal wrangling.

Still, the possibility of a shift to Schedule 3 is an indicator of changing attitudes at the federal level, offering hope to operators burdened by outdated policies.

A “Marijuana-Friendly” Administration?

Donald Trump’s return to the presidency comes with cautious optimism from cannabis operators. His past support for Florida’s legalization efforts sparked expectations of reform-friendly policies.

However, his appointments, including Attorney General nominee Pam Bondi, suggest a mixed bag. Bondi’s historical stance against marijuana raises concerns about federal policy under her watch. Despite this, advocates argue that Trump’s willingness to back certain measures could nudge Congress toward long-overdue banking and regulatory reforms.

The reality, though, may be slower progress. With a Republican-dominated Congress and other pressing priorities like border control and fentanyl crises, major reforms may not materialize until 2026 or later.

The IRS Battle Over Tax Burdens

The cannabis industry’s tax woes are reaching a critical point. Section 280E of the federal tax code, which prevents marijuana businesses from deducting regular expenses, continues to weigh heavily on the sector.

Last year:

  • Major cannabis operators ignored Section 280E and filed deductions anyway, setting up a legal showdown with the IRS.
  • The outcome of these disputes will create precedents that could redefine the tax landscape for marijuana companies.

The stakes are high, and both operators and the IRS are bracing for a confrontation that could reshape industry economics.

California’s Tax Crisis Deepens

California’s cannabis industry is grappling with mounting tax burdens, with retailers owing over $1.3 billion to the state. The situation could worsen with the state’s excise tax set to increase from 15% to 19% in July unless legislative action is taken.

Here’s why this matters:

  • High taxes are driving consumers to the illicit market, undermining legalization efforts.
  • The state’s budget shortfall of $20 billion makes it unlikely that lawmakers will offer much relief.

A tipping point is near. Industry leaders warn that without meaningful changes, California could lose its status as the cannabis capital of the U.S.

Crackdown on Hemp-Derived THC

While federal lawmakers delayed updating the Farm Bill in 2024, several states have moved to regulate hemp-derived THC products, which fall under a legal loophole.

Key developments include:

  • California’s ban on intoxicating hemp products.
  • Similar efforts in Texas, Tennessee, and other states where such products have gained popularity.

Observers believe federal regulation is the only sustainable solution. But for now, the clash between hemp and marijuana producers is poised to escalate.

Federal Prohibition Faces Legal Challenges

Marijuana’s federal prohibition could be heading to the Supreme Court. Plaintiffs argue that the 2005 ruling supporting prohibition is outdated and unconstitutional.

Here’s what’s at stake:

  • A reversal of the Supreme Court’s decision could invalidate federal prohibition entirely.
  • However, the legal process is slow, with a rejection by the U.S. Circuit Court of Appeals expected before any Supreme Court appeal.

A favorable ruling could transform the industry, but such a landmark decision may still be years away.

State-Level Reforms Stall

While some states, like Pennsylvania, continue to discuss legalization, progress is slow. The defeats in Florida and the Dakotas highlight the waning momentum of ballot-driven efforts.

Current trends:

  • Legislative-led reforms in states like Delaware and Minnesota show more promise, but they take time to implement.
  • Markets in those states remain closed, delaying economic benefits for operators and consumers.

For now, state-level changes appear to be on pause, with only incremental progress likely in 2025.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Canadian Cannabis Operator Entourage Agrees to Go Private in Pension Fund-Backed Deal
Nevada’s Titus and Minnesota’s Omar Lead the Congressional Cannabis Caucus: What’s Next?
Related posts
  • Related posts
  • More from author
Marijuana

Colorado THC Vapes Flooded with Converted Hemp, Experts Sound Alarm

January 31, 20260
Cannabis

California Smashes Own Record: $609 Million in Illegal Cannabis Destroyed

January 29, 20260
Marijuana

Trump Allies Push to Kill Arizona Adult-Use Marijuana Sales

January 28, 20260
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Colorado THC Vapes Flooded with Converted Hemp, Experts Sound Alarm
  • California Smashes Own Record: $609 Million in Illegal Cannabis Destroyed
  • Trump Allies Push to Kill Arizona Adult-Use Marijuana Sales
  • Florida’s Marijuana Legalization Battle Hits New Lows in 2026
  • Montana Cannabis Sales Smash Records with $327 Million Haul
  • Cannabis M&A Surge Sparks Hope After Trump Order
  • Massachusetts Cannabis Ban Hit by Fraud Claims in 2026 Vote
  • Texas Medical Cannabis Set to Explode in 2026
  • Cannabis Firms Face HR Compliance Crunch in 2026
  • Oregon Cannabis Sales Drop in 2025 Despite Record Harvests
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors